EdgarLookup

TransUnion — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that TransUnion filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
10%
Profit Margin
Net income ÷ revenue
4.1%
Return on Assets
Net income ÷ assets
1.48x
Debt-to-Equity
Total liabilities ÷ equity
+9.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.58B Feb 27, 2026
FY2025 Dec 31, 2024 $4.18B Feb 27, 2026
FY2023 Dec 31, 2023 $954.30M Feb 28, 2024
FY2023 Sep 30, 2023 $968.70M Feb 28, 2024
FY2023 Jun 30, 2023 $968.00M Feb 28, 2024
FY2023 Mar 31, 2023 $940.30M Feb 28, 2024
FY2023 Dec 31, 2022 $902.10M Feb 28, 2024
FY2023 Sep 30, 2022 $938.20M Feb 28, 2024
FY2023 Jun 30, 2022 $948.30M Feb 28, 2024
FY2023 Mar 31, 2022 $921.30M Feb 28, 2024

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $506.10M Feb 13, 2018
FY2017 Sep 30, 2017 $498.00M Feb 13, 2018
FY2017 Jun 30, 2017 $474.80M Feb 13, 2018
FY2017 Mar 31, 2017 $455.00M Feb 13, 2018
FY2017 Dec 31, 2016 $435.90M Feb 13, 2018
FY2017 Sep 30, 2016 $437.60M Feb 13, 2018
FY2017 Jun 30, 2016 $425.70M Feb 13, 2018
FY2017 Mar 31, 2016 $405.70M Feb 13, 2018
FY2016 Dec 31, 2015 $386.10M Feb 15, 2017
FY2016 Sep 30, 2015 $389.10M Feb 15, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $455.40M Feb 27, 2026
FY2025 Dec 31, 2024 $284.40M Feb 27, 2026
FY2023 Dec 31, 2023 $6.10M Feb 28, 2024
FY2023 Sep 30, 2023 ($318.80M) Feb 28, 2024
FY2023 Jun 30, 2023 $53.90M Feb 28, 2024
FY2023 Mar 31, 2023 $52.60M Feb 28, 2024
FY2023 Dec 31, 2022 $46.40M Feb 28, 2024
FY2023 Sep 30, 2022 $79.20M Feb 28, 2024
FY2023 Jun 30, 2022 $92.80M Feb 28, 2024
FY2023 Mar 31, 2022 $47.90M Feb 28, 2024

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $857.80M Feb 27, 2026
FY2025 Dec 31, 2024 $666.70M Feb 27, 2026
FY2023 Dec 31, 2023 $61.30M Feb 28, 2024
FY2023 Sep 30, 2023 ($236.30M) Feb 28, 2024
FY2023 Jun 30, 2023 $158.40M Feb 28, 2024
FY2023 Mar 31, 2023 $145.20M Feb 28, 2024
FY2023 Dec 31, 2022 $143.50M Feb 28, 2024
FY2023 Sep 30, 2022 $169.50M Feb 28, 2024
FY2023 Jun 30, 2022 $178.90M Feb 28, 2024
FY2023 Mar 31, 2022 $134.40M Feb 28, 2024

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.26B Feb 27, 2026
FY2025 Dec 31, 2024 $1.24B Feb 27, 2026
FY2025 Dec 31, 2023 $1.17B Feb 27, 2026
FY2023 Sep 30, 2023 $290.80M Feb 28, 2024
FY2023 Jun 30, 2023 $292.50M Feb 28, 2024
FY2023 Mar 31, 2023 $284.60M Feb 28, 2024
FY2024 Dec 31, 2022 $1.18B Feb 13, 2025
FY2023 Sep 30, 2022 $287.60M Feb 28, 2024
FY2023 Jun 30, 2022 $293.20M Feb 28, 2024
FY2023 Mar 31, 2022 $324.70M Feb 28, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $987.60M Feb 27, 2026
FY2025 Dec 31, 2024 $832.50M Feb 27, 2026
FY2025 Dec 31, 2023 $645.40M Feb 27, 2026
FY2024 Dec 31, 2022 $297.20M Feb 13, 2025
FY2023 Dec 31, 2021 $808.30M Feb 28, 2024
FY2022 Dec 31, 2020 $787.60M Feb 14, 2023
FY2021 Dec 31, 2019 $776.90M Feb 22, 2022
FY2020 Dec 31, 2018 $555.70M Feb 16, 2021
FY2019 Dec 31, 2017 $465.80M Feb 18, 2020
FY2018 Dec 31, 2016 $389.90M Feb 14, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $326.00M Feb 27, 2026
FY2025 Dec 31, 2024 $315.80M Feb 27, 2026
FY2025 Dec 31, 2023 $310.70M Feb 27, 2026
FY2024 Dec 31, 2022 $298.20M Feb 13, 2025
FY2023 Dec 31, 2021 $224.20M Feb 28, 2024
FY2022 Dec 31, 2020 $205.60M Feb 14, 2023
FY2021 Dec 31, 2019 $188.40M Feb 22, 2022
FY2020 Dec 31, 2018 $180.10M Feb 16, 2021
FY2019 Dec 31, 2017 $135.30M Feb 18, 2020
FY2018 Dec 31, 2016 $124.00M Feb 14, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.11B Feb 27, 2026
FY2025 Dec 31, 2024 $10.98B Feb 27, 2026
FY2024 Dec 31, 2023 $11.11B Feb 13, 2025
FY2023 Dec 31, 2022 $11.67B Feb 28, 2024
FY2022 Dec 31, 2021 $12.64B Feb 14, 2023
FY2021 Dec 31, 2020 $7.31B Feb 22, 2022
FY2020 Dec 31, 2019 $7.11B Feb 16, 2021
FY2019 Dec 31, 2018 $7.04B Feb 18, 2020
FY2018 Dec 31, 2017 $5.12B Feb 14, 2019
FY2017 Dec 31, 2016 $4.78B Feb 13, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.57B Feb 27, 2026
FY2025 Dec 31, 2024 $6.67B Feb 27, 2026
FY2024 Dec 31, 2023 $7.00B Feb 13, 2025
FY2023 Dec 31, 2022 $7.40B Feb 28, 2024
FY2022 Dec 31, 2021 $8.63B Feb 14, 2023
FY2021 Dec 31, 2020 $4.68B Feb 22, 2022
FY2020 Dec 31, 2019 $4.77B Feb 16, 2021
FY2019 Dec 31, 2018 $5.06B Feb 18, 2020
FY2018 Dec 31, 2017 $3.29B Feb 14, 2019
FY2017 Dec 31, 2016 $3.31B Feb 13, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.44B Feb 27, 2026
FY2025 Dec 31, 2024 $4.22B Feb 27, 2026
FY2024 Dec 31, 2023 $4.01B Feb 13, 2025
FY2023 Dec 31, 2022 $4.17B Feb 28, 2024
FY2022 Dec 31, 2021 $3.91B Feb 14, 2023
FY2021 Dec 31, 2020 $2.54B Feb 22, 2022
FY2020 Dec 31, 2019 $2.25B Feb 16, 2021
FY2019 Dec 31, 2018 $1.89B Feb 18, 2020
FY2018 Dec 31, 2017 $1.73B Feb 14, 2019
FY2017 Dec 31, 2016 $1.36B Feb 13, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.26B Feb 27, 2026
FY2025 Dec 31, 2024 $5.14B Feb 27, 2026
FY2025 Dec 31, 2023 $5.18B Feb 27, 2026
FY2024 Dec 31, 2022 $5.55B Feb 13, 2025
FY2023 Dec 31, 2021 $5.53B Feb 28, 2024
FY2022 Dec 31, 2020 $3.23B Feb 14, 2023
FY2021 Dec 31, 2019 $3.14B Feb 22, 2022
FY2020 Dec 31, 2018 $3.29B Feb 16, 2021
FY2018 Dec 31, 2017 $2.37B Feb 14, 2019
FY2018 Dec 31, 2016 $2.17B Feb 14, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.72B Feb 27, 2026
FY2025 Dec 31, 2024 $2.36B Feb 27, 2026
FY2024 Dec 31, 2023 $2.16B Feb 13, 2025
FY2023 Dec 31, 2022 $2.45B Feb 28, 2024
FY2022 Dec 31, 2021 $2.25B Feb 14, 2023
FY2021 Dec 31, 2020 $937.40M Feb 22, 2022
FY2020 Dec 31, 2019 $652.00M Feb 16, 2021
FY2019 Dec 31, 2018 $363.10M Feb 18, 2020
FY2018 Dec 31, 2017 $137.40M Feb 14, 2019
FY2017 Dec 31, 2016 ($303.80M) Feb 13, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $853.60M Feb 27, 2026
FY2025 Dec 31, 2024 $679.50M Feb 27, 2026
FY2024 Dec 31, 2023 $476.20M Feb 13, 2025
FY2023 Dec 31, 2022 $585.30M Feb 28, 2024
FY2022 Dec 31, 2021 $1.84B Feb 14, 2023
FY2021 Dec 31, 2020 $492.70M Feb 22, 2022
FY2021 Dec 31, 2019 $273.60M Feb 22, 2022
FY2021 Dec 31, 2018 $186.70M Feb 22, 2022
FY2020 Dec 31, 2017 $115.80M Feb 16, 2021
FY2019 Dec 31, 2016 $182.20M Feb 18, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.10B Feb 27, 2026
FY2024 Dec 31, 2024 $5.15B Feb 13, 2025
FY2023 Dec 31, 2023 $5.34B Feb 28, 2024
FY2022 Dec 31, 2022 $5.67B Feb 14, 2023
FY2021 Dec 31, 2021 $6.37B Feb 22, 2022
FY2020 Dec 31, 2020 $3.45B Feb 16, 2021
FY2019 Dec 31, 2019 $3.66B Feb 18, 2020
FY2018 Dec 31, 2018 $4.05B Feb 14, 2019
FY2017 Dec 31, 2017 $2.46B Feb 13, 2018
FY2016 Dec 31, 2016 $2.38B Feb 15, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2023 Dec 31, 2023 0 Feb 28, 2024
FY2023 Sep 30, 2023 (1) Feb 28, 2024
FY2023 Jun 30, 2023 0 Feb 28, 2024
FY2023 Mar 31, 2023 0 Feb 28, 2024
FY2023 Dec 31, 2022 0 Feb 28, 2024
FY2023 Sep 30, 2022 0 Feb 28, 2024
FY2023 Jun 30, 2022 0 Feb 28, 2024
FY2023 Mar 31, 2022 0 Feb 28, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2023 Dec 31, 2023 0 Feb 28, 2024
FY2023 Sep 30, 2023 (1) Feb 28, 2024
FY2023 Jun 30, 2023 0 Feb 28, 2024
FY2023 Mar 31, 2023 0 Feb 28, 2024
FY2023 Dec 31, 2022 0 Feb 28, 2024
FY2023 Sep 30, 2022 0 Feb 28, 2024
FY2023 Jun 30, 2022 0 Feb 28, 2024
FY2023 Mar 31, 2022 0 Feb 28, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 192.40M Feb 27, 2026
FY2025 Dec 31, 2024 194.90M Feb 27, 2026
FY2024 Dec 31, 2023 193.80M Feb 13, 2025
FY2023 Dec 31, 2022 192.70M Feb 28, 2024
FY2022 Dec 31, 2021 191.80M Feb 14, 2023
FY2021 Dec 31, 2020 190.50M Feb 22, 2022
FY2020 Dec 31, 2019 188.70M Feb 16, 2021
FY2019 Dec 31, 2018 185.70M Feb 18, 2020
FY2018 Dec 31, 2017 183.20M Feb 14, 2019
FY2017 Dec 31, 2016 183.20M Feb 13, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $90.50M Feb 27, 2026
FY2025 Dec 31, 2024 $82.70M Feb 27, 2026
FY2025 Dec 31, 2023 $81.80M Feb 27, 2026
FY2024 Dec 31, 2022 $77.80M Feb 13, 2025
FY2023 Dec 31, 2021 $69.80M Feb 28, 2024
FY2022 Dec 31, 2020 $57.60M Feb 14, 2023
FY2021 Dec 31, 2019 $56.80M Feb 22, 2022
FY2020 Dec 31, 2018 $41.60M Feb 16, 2021
FY2019 Dec 31, 2017 $0 Feb 18, 2020
FY2018 Dec 31, 2016 $0 Feb 14, 2019